Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Biotech Stocks page aggregates 6 articles covering catalysts, earnings moves, and company updates to help you spot opportunities and manage biotech investments more confidently.
72 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Kyntra Bio (KYNB) is on investors' radar as 2025 earnings wrap up. This guide breaks down what the Q4 results mean, h...
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
A major adviser boosted its stake in Savara by more than a million shares during the latest quarter, wading into a bi...
A focused $8 million investment could trigger a dramatic move in a biotech stock. Learn how three NDA filings and a d...
A practical guide to interpreting Champions Oncology earnings. We break down the numbers, trends, and what to watch n...
Capricor's small-cap biotech story hinges on milestones, cash runway, and clinical progress. This guide breaks down w...
HeartBeam heads into 2025 earnings with a mix of potential breakthroughs and headwinds. This guide explains what the ...
Zevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Stocks retreat as Novo Nordisk and Jefferies face analyst downgrades, while Talkspace advances toward a private-equit...
A practical, reader-friendly guide to what to expect in evaxion (evax) 2025 earnings. Learn the drivers, read the cal...